Brought to you by 
Hutchison China Meditech closes £37mm IPO on AIM
08 Jun 2006
Executive Summary
Hutchison China Meditech Ltd. (Chi-Med), the holding company of a health care group based in China (but itself incorporated in the Cayman Islands), has gone public over the AIM. It sold 14.55mm ordinary shares at 275 pence, for net proceeds of £37mm ($68mm). The company is a division of diversified, Hong Kong-based Hutchison Whampoa Ltd.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hutchison China Meditech closes £37mm IPO on AIM
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice